The debilitating skin disease Buruli ulcer (BU) is caused by infection with Mycobacterium ulcerans. While various hypotheses on potential reservoirs and vectors of M. ulcerans exist, the mode of transmission has remained unclear. Epidemiological studies have indicated that children below the age of four are less exposed to the pathogen and at lower risk of developing BU than older children. In the present study we compared the age at which children begin to develop antibody responses against M. ulcerans with the age pattern of responses to other pathogens transmitted by various mechanisms. A total of 1,352 sera from individuals living in the BU endemic Offin river valley of Ghana were included in the study. While first serological responses to the mosquito transmitted malaria parasite Plasmodium falciparum and to soil transmitted Strongyloides helminths emerged around the age of one and two years, sero-conversion for M. ulcerans and for the water transmitted trematode Schistosoma mansoni occurred at around four and five years, respectively. Our data suggest that exposure to M. ulcerans intensifies strongly at the age when children start to have more intense contact with the environment, outside the small movement range of young children. Further results from our serological investigations in the Offin river valley also indicate ongoing transmission of Treponema pallidum, the causative agent of yaws.
References
[1]
Junghanss T, Johnson RC, Pluschke G. Mycobacterium ulcerans disease. In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White N, editors. Manson`s tropical diseases. 23rd ed. [Edinburgh]: Saunders; 2014. pp. 519–531.
[2]
George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science. 1999;283: 854–857. pmid:9933171 doi: 10.1126/science.283.5403.854
[3]
Hong H, Coutanceau E, Leclerc M, Caleechurn L, Leadlay PF, Demangel C. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis. 2008;2: e325. doi: 10.1371/journal.pntd.0000325. pmid:18941518
[4]
Merritt RW, Walker ED, Small PLC, Wallace JR, Johnson PDR, Benbow ME, et al. Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis. 2010;4: e911. doi: 10.1371/journal.pntd.0000911. pmid:21179505
[5]
Portaels F, Meyers WM, Ablordey A, Castro AG, Chemlal K, de Rijk P, et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis. 2008;2: e178. doi: 10.1371/journal.pntd.0000178. pmid:18365032
[6]
Williamson HR, Mosi L, Donnell R, Aqqad M, Merritt RW, Small PLC. Mycobacterium ulcerans fails to infect through skin abrasions in a guinea pig infection model: implications for transmission. PLoS Negl Trop Dis. 2014;8: e2770. doi: 10.1371/journal.pntd.0002770. pmid:24722416
Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Scott JT, et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Tropical Medicine & International Health. 2004;9: 1297–1304. doi: 10.1111/j.1365-3156.2004.01339.x.
[9]
Bratschi MW, Bolz M, Minyem JC, Grize L, Wantong FG, Kerber S, et al. Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon. PLoS Negl Trop Dis. 2013;7: e2252. doi: 10.1371/journal.pntd.0002252. pmid:23785529
[10]
Landier J, Fontanet A, Texier G. Defining and targeting high-risk populations in Buruli ulcer. The Lancet Global Health. 2014;2: e629. doi: 10.1016/S2214-109X(14)70311-0. pmid:25442683
[11]
R？ltgen K, Bratschi MW, Ross A, Aboagye SY, Ampah KA, Bolz M, et al. Late onset of the serological response against the 18 kDa small heat shock protein of Mycobacterium ulcerans in children. PLoS Negl Trop Dis. 2014;8: e2904. doi: 10.1371/journal.pntd.0002904. pmid:24853088
[12]
Pidot SJ, Porter JL, Tobias NJ, Anderson J, Catmull D, Seemann T, et al. Regulation of the 18 kDa heat shock protein in Mycobacterium ulcerans: an alpha-crystallin orthologue that promotes biofilm formation. Mol Microbiol. 2010;78: 1216–1231. doi: 10.1111/j.1365-2958.2010.07401.x. pmid:21091506
[13]
Diaz D, D？beli H, Yeboah-Manu D, Mensah-Quainoo E, Friedlein A, Soder N, et al. Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans. Clin Vaccine Immunol. 2006;13: 1314–1321. doi: 10.1128/CVI.00254-06. pmid:17021247
[14]
Pidot SJ, Porter JL, Marsollier L, Chauty A, Migot-Nabias F, Badaut C, et al. Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. PLoS Negl Trop Dis. 2010;4: e872. doi: 10.1371/journal.pntd.0000872. pmid:21072233
[15]
Yeboah-Manu D, R？ltgen K, Opare W, Asan-Ampah K, Quenin-Fosu K, Asante-Poku A, et al. Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans. PLoS Negl Trop Dis. 2012;6: e1460. doi: 10.1371/journal.pntd.0001460. pmid:22253937
[16]
Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, Asiedu K, et al. Buruli ulcer in Ghana: results of a national case search. Emerging Infect Dis. 2002;8: 167–170. doi: 10.3201/eid0802.010119. pmid:11897068
[17]
Se？a AC, White BL, Sparling PF. Novel Treponema pallidum Serologic Tests: A Paradigm Shift in Syphilis Screening for the 21st Century. Clin Infect Dis. 2010;51: 700–708. doi: 10.1086/655832. pmid:20687840
[18]
Castro AR, Esfandiari J, Kumar S, Ashton M, Kikkert SE, Park MM, et al. Novel Point-of-Care Test for Simultaneous Detection of Nontreponemal and Treponemal Antibodies in Patients with Syphilis. J Clin Microbiol. 2010;48: 4615–4619. doi: 10.1128/JCM.00624-10. pmid:20881177
[19]
Ayove T, Houniei W, Wangnapi R, Bieb SV, Kazadi W, Luke L- N, et al. Sensitivity and specificity of a rapid point-of-care test for active yaws: a comparative study. Lancet Glob Health. 2014;2: e415–421. doi: 10.1016/S2214-109X(14)70231-1. pmid:25103395
[20]
Nickel B, Sayasone S, Vonghachack Y, Odermatt P, Marti H. Schistosoma mansoni antigen detects Schistosoma mekongi infection. Acta Tropica. 2015;141, Part B: 310–314. doi: 10.1016/j.actatropica.2014.08.001.
[21]
Rodrigues RM, de Oliveira MC, Sopelete MC, Silva DAO, Campos DMB, Taketomi EA, et al. IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen. Parasitol Res. 2007;101: 1209–1214. doi: 10.1007/s00436-007-0602-z. pmid:17610082
[22]
Eamudomkarn C, Sithithaworn P, Sithithaworn J, Kaewkes S, Sripa B, Itoh M. Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis. Parasitol Res. 2015;114: 2543–2551. doi: 10.1007/s00436-015-4458-3. pmid:25877389
[23]
Buonfrate D, Sequi M, Mejia R, Cimino RO, Krolewiecki AJ, Albonico M, et al. Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection. PLoS Negl Trop Dis. 2015;9: e0003491. doi: 10.1371/journal.pntd.0003491. pmid:25668740
[24]
Keiser J, Thiemann K, Endriss Y, Utzinger J. Strongyloides ratti: in vitro and in vivo activity of tribendimidine. PLoS Negl Trop Dis. 2008;2: e136. doi: 10.1371/journal.pntd.0000136. pmid:18235851
[25]
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1: 307–310. pmid:2868172 doi: 10.1016/s0140-6736(86)90837-8
[26]
Silvie O, Franetich J-F, Charrin S, Mueller MS, Siau A, Bodescot M, et al. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem. 2004;279: 9490–9496. doi: 10.1074/jbc.M311331200. pmid:14676185
[27]
Van den Hoogen LL, Griffin JT, Cook J, Sepúlveda N, Corran P, Conway DJ, et al. Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar J. 2015;14: 416. doi: 10.1186/s12936-015-0939-1. pmid:26492873
[28]
Helb DA, Tetteh KKA, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci USA. 2015;112: E4438–4447. doi: 10.1073/pnas.1501705112. pmid:26216993
[29]
Johnson PDR, Lavender CJ. Correlation between Buruli ulcer and vector-borne notifiable diseases, Victoria, Australia. Emerging Infect Dis. 2009;15: 614–615. doi: 10.3201/eid1504.081162. pmid:19331750
[30]
Lavender CJ, Fyfe JAM, Azuolas J, Brown K, Evans RN, Ray LR, et al. Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia. PLoS Negl Trop Dis. 2011;5: e1305. doi: 10.1371/journal.pntd.0001305. pmid:21949891
[31]
R？ltgen K, Qi W, Ruf M-T, Mensah-Quainoo E, Pidot SJ, Seemann T, et al. Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana. PLoS Negl Trop Dis. 2010;4: e751. doi: 10.1371/journal.pntd.0000751. pmid:20652033
[32]
Vandelannoote K, Jordaens K, Bomans P, Leirs H, Durnez L, Affolabi D, et al. Insertion Sequence Element Single Nucleotide Polymorphism Typing Provides Insights into the Population Structure and Evolution of Mycobacterium ulcerans across Africa. Appl Environ Microbiol. 2014;80: 1197–1209. doi: 10.1128/AEM.02774-13. pmid:24296504
[33]
Lodh N, Naples JM, Bosompem KM, Quartey J, Shiff CJ. Detection of Parasite-Specific DNA in Urine Sediment Obtained by Filtration Differentiates between Single and Mixed Infections of Schistosoma mansoni and S. haematobium from Endemic Areas in Ghana. PLoS ONE. 2014;9: e91144. doi: 10.1371/journal.pone.0091144. pmid:24632992
[34]
Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368: 1106–1118. doi: 10.1016/S0140-6736(06)69440-3. pmid:16997665
[35]
Woolhouse MEJ. Patterns in Parasite Epidemiology: The Peak Shift. Parasitology Today. 1998;14: 428–434. doi: 10.1016/S0169-4758(98)01318-0. pmid:17040835
[36]
Mitjà O, Asiedu K, Mabey D. Yaws. Lancet. 2013;381: 763–773. doi: 10.1016/S0140-6736(12)62130-8. pmid:23415015
[37]
Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995;8: 1–21. pmid:7704889
[38]
Mitjà O, Houinei W, Moses P, Kapa A, Paru R, Hays R, et al. Mass treatment with single-dose azithromycin for yaws. N Engl J Med. 2015;372: 703–710. doi: 10.1056/NEJMoa1408586. pmid:25693010
[39]
Mitjà O, Marks M, Konan DJP, Ayelo G, Gonzalez-Beiras C, Boua B, et al. Global epidemiology of yaws: a systematic review. Lancet Glob Health. 2015;3: e324–331. doi: 10.1016/S2214-109X(15)00011-X. pmid:26001576
[40]
Organization WH. Summary report of a consultation on the eradication of yaws, 5–7 March 2012, Morges, Switzerland. Rapport sommaire d’une consultation sur l’éradication du pian, 5–7 mars 2012, Morges, Suisse. 2012;
[41]
Ghinai R, El-Duah P, Chi K-H, Pillay A, Solomon AW, Bailey RL, et al. A cross-sectional study of “yaws” in districts of Ghana which have previously undertaken azithromycin mass drug administration for trachoma control. PLoS Negl Trop Dis. 2015;9: e0003496. doi: 10.1371/journal.pntd.0003496. pmid:25632942
